This article was originally distributed via PRWeb. PRWeb, WorldNow and this Site make no warranties or representations in connection therewith.
SOURCE: Actos Center
The Actos Resource Center is the Web’s largest source for information on Actos warnings, research, side effects and legal news. Visit http://www.ActosCancer.com
Los Angeles, CA (PRWEB) August 03, 2012
The Actos Bladder Cancer Center, a patient advocacy group, is alerting patients who suffered side effects after taking the diabetes drug Actos that the judge overseeing injury litigation has now scheduled the first trial.
Anyone who has experienced symptoms of bladder cancer after taking Actos is encouraged to visit their doctor and speak with a lawyer about their legal rights as soon as possible.
Drug experts have warned that long-term use of Actos may be linked to bladder cancer for more than a year. On June 10, 2011, CBS News reported that Germany and France banned the drug after a study indicated long-term use could increase bladder cancer occurrences by as much as 40%. The FDA followed up on June 15, 2011 by issuing its own Actos alert.
In April, the Canadian Press reported that Health Canada had issued a warning after a study there showed a greater than 40% increased risk of bladder cancer from Actos.
On May 31st, the British Medical Journal published a study by researchers at McGill University in Montreal showing the increased bladder cancer risks from long-term Actos use may actually be as high as 83%.
According to Bloomberg News on March 13, 2012, Takeda Pharmaceuticals could face as many as 10,000 lawsuits from Actos patients afflicted with bladder cancer. All Actos lawsuits have been consolidated to a special multi-district federal court in Louisiana. The case is known as In Re: Actos Products Liability Litigation, MDL 2299, U.S. District Court, Western District of Louisiana (Lafayette).
Citing the number of cases likely to be filed and to allow for evidence gathering, the judge in charge of Actos litigation, Judge Rebecca Doherty, recently issued a scheduling order on July 13th setting the first Actos trial for November 2014.
Anyone who has suffered a bladder cancer or heart attack side effect after taking Actos is urged to speak with a lawyer about their legal options.
The Actos Resource Center cautions that it is important for anyone affected to choose a lawyer with experience in this specialized MDL process. The Actos Resource Center works only with qualified Actos lawyers who are actively involved in this litigation and have handled thousands of cases.
For more information on the research, warnings, side effects and legal options relating to the drug Actos, or to speak with a lawyer, visit http://www.ActosCancer.com.
For the original version on PRWeb visit: http://www.prweb.com/releases/prwebactos/lawyers/prweb9766264.htm